RAYMOND L. FARRELL; GERALD T. ROLING; DONALD O. CASTELL
Oral bethanechol has been shown to produce a sustained rise in lower esophageal sphincter pressure. We studied its effect on 20 patients with chronic heartburn refractory to usual therapy. All patients had a positive Bernstein test and manometric evidence of lower esophageal sphincter incompetence. In a randomized double-blind crossover study, each patient received either 25 mg bethanechol or placebo four times/day for 2 months; after a 2-month rest period the opposite treatment (drug or placebo) was given for 2 months. The patients' symptoms were evaluated each month of the study. Antacid, taken ad lib., was quantitated monthly. The results showed significant (P < 0.05) improvement in heartburn symptoms and decreased antacid use during bethanechol therapy. Bethanechol may be a welcome addition to therapy of refractory heartburn.
Learn more about subscription options.
Register Now for a free account.
FARRELL RL, ROLING GT, CASTELL DO. Cholinergic Therapy of Chronic Heartburn: A Controlled Trial. Ann Intern Med. 1974;80:573–576. doi: 10.7326/0003-4819-80-5-573
Download citation file:
Published: Ann Intern Med. 1974;80(5):573-576.
Esophageal Disorders, Gastroenterology/Hepatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only